• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    60 Biggest Movers From Yesterday

    4/26/22 4:58:37 AM ET
    $AGE
    $ARDX
    $ATER
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGE alert in real time by email

    Gainers

    • Nkarta, Inc. (NASDAQ:NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.
    • ION Geophysical Corporation (NYSE:IO) gained 46.3% to close at $0.6880 on above-average volume.
    • Cango Inc. (NYSE:CANG) shares rose 40.7% to close at $3.32. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 40.6% to settle at $1.87 on above-average volume.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares gained 37.7% to close at $1.68. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) climbed 37.5% to settle at $3.92.
    • Ardelyx, Inc. (NASDAQ:ARDX) climbed 31.8% to close at $0.9859 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.
    • GWG Holdings, Inc. (NASDAQ:GWGH) jumped 31.1% to close at $2.99.
    • ImmuCell Corporation (NASDAQ:ICCC) gained 29% to settle at $10.71.
    • ImmuCell recently said it sees preliminary FY22 sales of $21.1 million.
    • Veru Inc. (NASDAQ:VERU) gained 25.8% to close at $14.10. Veru highlighted presentation of Phase 2 Sabizabulin at the 32nd European Congress of Clinical Microbiology & Infectious Diseases.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 20.4% to close at $4.01 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
    • Swvl Holdings Corp. (NASDAQ:SWVL) shares rose 18.6% to close at $7.67 after the company announced its agreement to acquire Volt Lines.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) jumped 18.6% to settle at $1.59.
    • RiceBran Technologies (NASDAQ:RIBT) surged 18.3% to close at $0.6287.
    • iCAD, Inc. (NASDAQ:ICAD) rose 18.2% to close at $3.57.
    • BigBear.ai Holdings, Inc. (NASDAQ:BBAI) gained 18.1% to close at $10.10.
    • AgeX Therapeutics, Inc. (NYSE:AGE) jumped 17.7% to settle at $1.00. AgeX Therapeutics, last month, reported Q4 earnings results.
    • CinCor Pharma, Inc. (NASDAQ:CINC) surged 17.3% to close at $25.48.
    • Aterian, Inc. (NASDAQ:ATER) climbed 16.4% to settle at $5.11.
    • IT Tech Packaging, Inc. (NYSE:ITP) shares rose 16.4% to close at $0.33. IT Tech Packaging, last monthm said Q4 EPS and sales results were higher year over year.
    • INmune Bio, Inc. (NASDAQ:INMB) gained 16.2% to settle at $7.96.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) jumped 16% to close at $9.29.
    • DatChat, Inc. (NASDAQ:DATS) rose 15.7% to close at $1.99.
    • Zymergen Inc. (NASDAQ:ZY) gained 15.2% to settle at $2.05.
    • Dogness (International) Corporation (NASDAQ:DOGZ) gained 15.1% to close at $4.04.
    • PaySign, Inc. (NASDAQ:PAYS) rose 13.5% to settle at $1.93.
    • Silicon Motion Technology Corporation (NASDAQ:SIMO) gained 12.9% to close at $87.02 after Bloomberg reported that the company exploring a potential sale amid takeover interest.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) gained 12.7% to close at $2.22.
    • PS Business Parks, Inc. (NYSE:PSB) climbed 11.8% to close at $187.50 after the company announced it will be acquired by affiliates of Blackstone Real Estate for $7.6 billion.
    • Cenntro Electric Group Limited (NASDAQ:CENN) gained 10.6% to settle at $1.88 after gaining around 7% on Friday.
    • BioLife Solutions, Inc. (NASDAQ:BLFS) rose 9.5% to close at $13.79. Oppenheimer upgraded BioLife Solns from Perform to Outperform and announced a $28 price target.
    • Joby Aviation, Inc. (NYSE:JOBY) jumped 6.8% to close at $5.31.
    • Graphite Bio, Inc. (NASDAQ:GRPH) gained 6.8% to settle at $4.27.
    • Eros STX Global Corporation (NYSE:ESGC) rose 6.7% to close at $2.39.

     

    Losers

    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares dipped 56.2% to settle at $0.7889 on Monday. Clarus Therapeutics reporetd pricing of upsized underwritten public offering at $1.10 per share.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares tumbled 55.8% to close at $2.88 on Monday after the company announced the Phase 2a clinical trial of ETX-810 in diabetic peripheral neuropathic pain did not achieve the primary endpoint. The company also announced it elected to delay enrollment of its Phase 2a clinical trials of ETX-155 in major depressive disorder and perimenopausal depression.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 44.9% to close at $14.57. ToughBuilt Industries reported a 1-for-150 reverse stock split as part of Nasdaq compliance plan.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) dipped 36% to settle at $4.21. Avadel Pharmaceuticals announced interim data from the open-label RESTORE study at the 2022 American Academy of Neurology Annual Meeting.
    • Cypress Environmental Partners, L.P. (NYSE:CELP) fell 34.5% to close at $0.4212 after the company said an affiliate of Argonaut Private Equity has acquired 100% of Cypress’s senior secured debt from the seven existing lenders.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) fell 26.4% to close at $0.3267 on above-average volume.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) fell 25.6% to close at $0.7890.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) dropped 22% to close at $30.50 after the company reported it was informed by the FDA that chemistry, manufacturing, and control issues identified during the FDA's review of its NDA for its AXS-07 product candidate are unresolved.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) fell 20.5% to close at $0.9620.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 20.2% to close at $2.10.
    • EuroDry Ltd. (NASDAQ:EDRY) fell 19.1% to close at $32.21. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
    • Pineapple Energy Inc. (NASDAQ:PEGY) dipped 17.1% to settle at $3.35.
    • Brickell Biotech, Inc. (NASDAQ:BBI) fell 17% to settle at $0.2615.
    • Navios Maritime Holdings Inc. (NYSE:NM) dropped 15.4% to close at $3.73.
    • Bone Biologics Corporation (NASDAQ:BBLG) fell 14.8% to settle at $2.02.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 14.4% to close at $1.94. Vallon Pharmaceuticals shares jumped more than 100% on Friday after the company announced a review of strategic alternatives.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) dropped 14.1% to close at $1.34.
    • Leju Holdings Limited (NYSE:LEJU) fell 14% to settle at $0.43.
    • COMSovereign Holding Corp. (NASDAQ:COMS) fell 13.9% to settle at $0.3964.
    • Nordic American Tankers Limited (NYSE:NAT) dropped 12.5% to close at $2.44.
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) dipped 12.4% to close at $2.3750.
    • HighPeak Energy, Inc. (NASDAQ:HPK) dropped 11.5% to close at $33.35.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 11.3% to close at $26.91. Philips reported a first-quarter FY22 sales growth of 2.6% year-on-year to €3.9 billion.
    • Golden Ocean Group Limited (NASDAQ:GOGL) fell 10.9% to close at $11.66.
    • Cyngn Inc. (NASDAQ:CYN) fell 10% to close at $2.42 after climbing around 27% on Friday. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
    • TradeUP Global Corporation (NASDAQ:TUGC) dipped 7.3% to settle at $9.22.
    Get the next $AGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGE
    $ARDX
    $ATER
    $AVDL

    CompanyDatePrice TargetRatingAnalyst
    Nordic American Tankers Limited
    $NAT
    4/22/2026$4.50In-line → Underperform
    Evercore ISI
    Joby Aviation Inc.
    $JOBY
    2/26/2026$18.00Neutral → Buy
    H.C. Wainwright
    Axsome Therapeutics Inc.
    $AXSM
    2/24/2026$230.00Outperform
    Wolfe Research
    EuroDry Ltd.
    $EDRY
    2/12/2026$23.50Market Perform → Outperform
    Noble Capital Markets
    Silicon Motion Technology Corporation
    $SIMO
    1/22/2026Outperform
    William Blair
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    Axsome Therapeutics Inc.
    $AXSM
    1/8/2026$204.00Overweight → Equal-Weight
    Morgan Stanley
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    More analyst ratings

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nordic American Tanker downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Nordic American Tanker from In-line to Underperform and set a new price target of $4.50

    4/22/26 7:53:45 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    Joby Aviation upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Joby Aviation from Neutral to Buy and set a new price target of $18.00

    2/26/26 7:10:22 AM ET
    $JOBY
    Aerospace
    Industrials

    Wolfe Research initiated coverage on Axsome Therapeutics with a new price target

    Wolfe Research initiated coverage of Axsome Therapeutics with a rating of Outperform and set a new price target of $230.00

    2/24/26 7:45:48 AM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    SEC Filings

    View All

    SEC Form DEFA14A filed by Nkarta Inc.

    DEFA14A - Nkarta, Inc. (0001787400) (Filer)

    4/23/26 4:41:50 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Nkarta Inc.

    DEF 14A - Nkarta, Inc. (0001787400) (Filer)

    4/23/26 4:41:05 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by INmune Bio Inc.

    DEF 14A - Inmune Bio, Inc. (0001711754) (Filer)

    4/23/26 4:06:11 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:45 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:29 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Commercial Officer Maizel Ari exercised 7,500 shares at a strike of $70.73 and sold $1,368,150 worth of shares (7,500 units at $182.42) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:01:34 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

    BOTHELL, Wash., April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first quarter financial results will be released on May 7, 2026. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update. To access the webcast, log onto the Investor Relations page of the BioLife Solutions websit

    4/23/26 4:03:00 PM ET
    $BLFS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Reuben Brothers Unveil Joby Vertiport at Century Plaza

    LOS ANGELES, April 23, 2026 /PRNewswire/ -- Reuben Brothers today announced an alliance with Joby Aviation (NYSE:JOBY) to establish an air taxi vertiport at Park Elm Residences at Century Plaza, South Tower in Century City, Los Angeles. The vertiport will utilize the building's existing helipad to accommodate operations and charging for Joby's all-electric, vertical take-off and landing ("eVTOL") aircraft, which is both quiet and has zero operating emissions. Joby is in the final stages of certifying its revolutionary aircraft for commercial operations and last month completed a

    4/23/26 9:00:00 AM ET
    $JOBY
    Aerospace
    Industrials

    Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

    April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa

    4/23/26 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Leadership Updates

    Live Leadership Updates

    View All

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BigBear.ai Announces Appointments of Jo Ann Bjornson as Chief Human Resources Officer and Alex Thompson as Chief Corporate Affairs Officer

    BigBear.ai (NYSE:BBAI), a specialized defense technology company, providing mission-ready AI for national security and travel & trade customers, today announced the appointment of Jo Ann Bjornson as Chief Human Resources Officer (CHRO) and Alex Thompson as Chief Corporate Affairs Officer (CCAO). These additions to the executive leadership team underscore BigBear.ai's commitment to driving growth, fostering innovation, and strengthening its position as a trusted partner in mission-critical environments. Jo Ann Bjornson joins BigBear.ai as CHRO, bringing over 25 years of experience in human resources leadership within federal contracting and commercial markets. Recognized as one of Washingt

    4/8/26 9:15:00 AM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

    WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Rajani Dinavahi, MD, as Chief Medical Officer (CMO). Dr. Dinavahi brings more than two decades of experience in healthcare and biotechnology, spanning multiple therapeutic areas and modalities. She has extensive experience across immuno-oncology, autoimmune diseases, metabolic disease, nephrology and transplantation, with a track record of advancing programs from early development through Phase 3 and regulatory approval. Dr. Dinavahi m

    4/1/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    $AGE
    $ARDX
    $ATER
    $AVDL
    Financials

    Live finance-specific insights

    View All

    BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

    BOTHELL, Wash., April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first quarter financial results will be released on May 7, 2026. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update. To access the webcast, log onto the Investor Relations page of the BioLife Solutions websit

    4/23/26 4:03:00 PM ET
    $BLFS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    HighPeak Energy, Inc. Announces 2026 First Quarter Earnings Release and Conference Call Dates

    FORT WORTH, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (NASDAQ:HPK) ("HighPeak Energy"), today announced that it plans to release its 2026 first quarter financial and operating results after the close of trading on Wednesday, May 6, 2026. HighPeak Energy will host a conference call and webcast on Thursday, May 7, 2026 at 10:00 a.m. Central Time for investors and analysts to discuss its 2026 first quarter financial results and operational highlights. Participants may register for the call here. Access to the live audio-only webcast and replay of the earnings release conference call may be found here. A live broadcast of the earnings conference call will also be availab

    4/23/26 6:05:00 AM ET
    $HPK
    Oil & Gas Production
    Energy

    Joby Aviation to Report First Quarter 2026 Financial Results

    Joby Aviation, Inc. (NYSE:JOBY), a company developing electric air taxis for commercial passenger service, today announced that it expects to release its first quarter 2026 financial results after market close on Tuesday, May 5, 2026, and to host a webcast at 5:00 pm ET on the same day. The webcast will be publicly available in the Upcoming Events section of the company website, www.jobyaviation.com. If unable to attend the webcast, to listen by phone, please dial 1-877-407-9719 or 1-201-378-4906. A replay of the webcast will be available on the company website following the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20

    4/22/26 6:15:00 AM ET
    $JOBY
    Aerospace
    Industrials

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care